BofA Securities Downgrades XP Inc(XP.US) to Hold Rating
XP Inc. Downgraded to Neutral at BofA Amid Brazil Financial Rating Changes
BofA Securities Downgrades XP to Neutral From Buy, Price Target Is $16
XP Is Maintained at Equal-Weight by Morgan Stanley
XP Analyst Ratings
Morgan Stanley Maintains XP Inc(XP.US) With Hold Rating, Cuts Target Price to $21
UBS Maintains XP Inc(XP.US) With Hold Rating, Cuts Target Price to $19
BofA Securities Maintains XP Inc(XP.US) With Buy Rating, Maintains Target Price $25
Morgan Stanley Maintains XP Inc(XP.US) With Hold Rating, Maintains Target Price $24
J.P. Morgan Maintains XP Inc(XP.US) With Buy Rating, Cuts Target Price to $29
XP Analyst Ratings
JP Morgan Maintains Overweight on XP, Raises Price Target to $29
Citi Maintains XP Inc(XP.US) With Buy Rating
Morgan Stanley Maintains XP Inc(XP.US) With Hold Rating, Maintains Target Price $24
XP Inc: Hold Rating Maintained Amid Stable Valuation and Modest Earnings Adjustment
BofA Securities Maintains XP Inc(XP.US) With Buy Rating, Maintains Target Price $25
Morgan Stanley Maintains XP Inc(XP.US) With Hold Rating, Maintains Target Price $24
BofA Securities Maintains XP Inc(XP.US) With Buy Rating, Maintains Target Price $25
Citi Maintains XP Inc(XP.US) With Buy Rating, Maintains Target Price $27
Strong Performance and Promising Outlook Justify Buy Rating for XP Inc.